Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System
暂无分享,去创建一个
David Madigan | Martijn J Schuemie | Patrick B Ryan | Kristina Juhlin | Tomas Bergvall | G Niklas Norén
[1] Johan Hopstadius,et al. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery , 2011, Statistical methods in medical research.
[2] N. Shah,et al. Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System , 2013, Clinical pharmacology and therapeutics.
[3] B. Armstrong,et al. A simple estimator of minimum detectable relative risk, sample size, or power in cohort studies. , 1987, American journal of epidemiology.
[4] M. Lindquist,et al. Quality criteria for early signals of possible adverse drug reactions , 1990, The Lancet.
[5] M. Schuemie. Safety surveillance of longitudinal databases: further methodological considerations , 2012, Pharmacoepidemiology and drug safety.
[6] M D Rawlins,et al. Spontaneous reporting of adverse drug reactions. , 1986, The Quarterly journal of medicine.
[7] M. Lindquist,et al. An ABC of Drug-Related Problems , 2000, Drug safety.
[8] Janet Woodcock,et al. Role of postmarketing surveillance in contemporary medicine. , 2011, Annual review of medicine.
[9] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[10] C P Farrington,et al. Case series analysis of adverse reactions to vaccines: a comparative evaluation. , 1996, American journal of epidemiology.
[11] Benjamin M. Smith,et al. Adverse events associated with treatment of latent tuberculosis in the general population , 2011, Canadian Medical Association Journal.
[12] G. Niklas Norén,et al. Temporal pattern discovery for trends and transient effects: its application to patient records , 2008, KDD.
[13] M. Maclure. The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.
[14] David Madigan,et al. Disproportionality methods for pharmacovigilance in longitudinal observational databases , 2013, Statistical methods in medical research.
[15] S Suissa,et al. THE CASE‐TIME-CONTROL DESIGN , 1995, Epidemiology.
[16] K. Tomecki. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines: Carson JL, Strom BL, Duff A, et al. Ann Intern Med 1993;119:576-83 , 1995 .
[17] R. Tannen,et al. Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings , 2009, BMJ : British Medical Journal.
[18] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[19] Patrick B. Ryan,et al. Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System , 2013, Drug Safety.
[20] M. Schuemie,et al. Defining a Reference Set to Support Methodological Research in Drug Safety , 2013, Drug Safety.
[21] J. Hallas. Evidence of Depression Provoked by Cardiovascular Medication: A Prescription Sequence Symmetry Analysis , 1996, Epidemiology.
[22] B. Strom,et al. Acute Liver Disease Associated with Erythromycins, Sulfonamides, and Tetracyclines , 1993, Annals of Internal Medicine.
[23] D. Madigan,et al. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership , 2012, Statistics in medicine.
[24] M D Rawlins,et al. Spontaneous reporting of adverse drug reactions. I: the data. , 1988, British journal of clinical pharmacology.
[25] A. Bate,et al. Safety surveillance of longitudinal databases: results on real‐world data , 2012 .
[26] A. Dyer,et al. Dietary Beta‐Carotene, Vitamin C, and Risk of Prostate Cancer , 1996, Epidemiology.
[27] G. Niklas Norén,et al. Temporal pattern discovery in longitudinal electronic patient records , 2010, Data Mining and Knowledge Discovery.
[28] K. Clauson. Drug-Induced Diseases: Prevention, Detection, and Management , 2005 .